About the Trial: Our Client is conducting a significant clinical trial to investigate the effects of oral semaglutide versus placebo on cardiovascular outcomes in up to 20,000 participants with type 2 diabetes.
Participants will take part remotely by completing questionnaires on their own devices or during telephone interviews with research nurses.
Study treatments will be sent to participants' homes by post.